Cui Jie, Kawai Tasuo, Irani Zubin
Nephrology Division, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
Division of Transplant Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
Semin Dial. 2015 Sep-Oct;28(5):548-51. doi: 10.1111/sdi.12362. Epub 2015 Apr 1.
Indwelling central venous catheters have been reported to increase the risk of superior venous cava (SVC) syndrome. This case report describes the development of acute SVC syndrome in a 28-year-old woman with end-stage renal disease implanted with a left-side hemodialysis reliable outflow graft and a right-side double lumen hemodialysis catheter via internal jugular veins. Her symptoms were not alleviated after catheter removal and systemic anticoagulation therapy. She was eventually treated with catheter-directed thrombolysis and a predischarge computer tomographic venogram on postthrombolytic procedure day 7 showed patent central veins and patient remained asymptomatic. This case demonstrates that catheter-directed thrombolysis can be safely employed to treat refractory catheter-induced acute SVC syndrome in end-stage renal disease patients.
据报道,留置中心静脉导管会增加上腔静脉(SVC)综合征的风险。本病例报告描述了一名28岁终末期肾病女性发生急性SVC综合征的情况,该患者通过颈内静脉植入了左侧血液透析可靠流出道移植物和右侧双腔血液透析导管。拔除导管并进行全身抗凝治疗后,她的症状并未缓解。她最终接受了导管定向溶栓治疗,溶栓术后第7天出院前的计算机断层静脉造影显示中心静脉通畅,患者仍无症状。本病例表明,导管定向溶栓可安全用于治疗终末期肾病患者难治性导管所致急性SVC综合征。